Legend Biotech shares first in vivo CAR-T data, its next act after Carvykti
Legend Biotech’s long-awaited first showing of in vivo CAR-T data is here, fueling momentum in the growing field. Legend reported results Tuesday on 12 lymphoma patients from an investigator-initiated trial conducted in China, showing that ...
Ying Huang, Legend Biotech CEO June 2, 2026 09:31 AM EDTUpdated 09:54 AM R&DCell/Gene Tx Legend Biotech shares first in vivo CAR-T data, its next act after Carvykti Lei Lei Wu News Reporter Legend Biotech’s long-awaited first showing of in vivo CAR-T data is here, fueling momentum in the growing field. Legend reported results Tuesday on 12 lymphoma … Sign up to read this article for free. Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER
comments(0)
5-min edit window · permanent after that